Stay updated on Nivolumab With Azacitidine in AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With Azacitidine in AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page. This appears to be an administrative version update with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2025-12-01T16:54:02.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Publications section updated to clarify that entries are automatically filled from PubMed, and the page template revision is noted (additions: v3.3.1; deletions: v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:07:54.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Funding-status notice about lapses in government funding has been removed from the page, reducing visibility of site-wide operating status for users viewing this study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:26:50.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No significant changes to core study content, design, arms, outcomes, or eligibility criteria were detected; observed differences are limited to minor text formatting and an updated last-modified timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:13:34.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If there are no other changes, this is the main shift.
    Difference
    2%
    Check dated 2025-10-05T10:13:44.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Significant content update: new immunology terms and concepts added and the page version updated to v3.1.0; the previous v3.0.2 reference was removed.
    Difference
    0.7%
    Check dated 2025-09-28T03:16:38.000Z thumbnail image

Stay in the know with updates to Nivolumab With Azacitidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.